LIMN
Price
$0.98
Change
+$0.07 (+7.69%)
Updated
Dec 3 closing price
Capitalization
N/A
Intraday BUY SELL Signals
SCNI
Price
$1.15
Change
+$0.12 (+11.65%)
Updated
Dec 3 closing price
Capitalization
3.99M
Intraday BUY SELL Signals
Interact to see
Advertisement

LIMN vs SCNI

Header iconLIMN vs SCNI Comparison
Open Charts LIMN vs SCNIBanner chart's image
Liminatus Pharma
Price$0.98
Change+$0.07 (+7.69%)
Volume$91.5K
CapitalizationN/A
Scinai Immunotherapeutics
Price$1.15
Change+$0.12 (+11.65%)
Volume$51.94K
Capitalization3.99M
LIMN vs SCNI Comparison Chart in %
LIMN
Daily Signal:
Gain/Loss:
SCNI
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
LIMN vs. SCNI commentary
Dec 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LIMN is a Hold and SCNI is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Dec 04, 2025
Stock price -- (LIMN: $0.90 vs. SCNI: $1.03)
Brand notoriety: LIMN and SCNI are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: LIMN: 10% vs. SCNI: 55%
Market capitalization -- LIMN: $0 vs. SCNI: $3.99M
LIMN [@Biotechnology] is valued at $0. SCNI’s [@Biotechnology] market capitalization is $3.99M. The market cap for tickers in the [@Biotechnology] industry ranges from $117.5B to $0. The average market capitalization across the [@Biotechnology] industry is $2.19B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

LIMN’s FA Score shows that 1 FA rating(s) are green whileSCNI’s FA Score has 2 green FA rating(s).

  • LIMN’s FA Score: 1 green, 4 red.
  • SCNI’s FA Score: 2 green, 3 red.
According to our system of comparison, SCNI is a better buy in the long-term than LIMN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

LIMN’s TA Score shows that 5 TA indicator(s) are bullish while SCNI’s TA Score has 6 bullish TA indicator(s).

  • LIMN’s TA Score: 5 bullish, 3 bearish.
  • SCNI’s TA Score: 6 bullish, 3 bearish.
According to our system of comparison, SCNI is a better buy in the short-term than LIMN.

Price Growth

LIMN (@Biotechnology) experienced а +1.91% price change this week, while SCNI (@Biotechnology) price change was +11.53% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.32%. For the same industry, the average monthly price growth was +1.23%, and the average quarterly price growth was +54.93%.

Industries' Descriptions

@Biotechnology (+0.32% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SCNI YTD gains are higher at: -69.208 vs. LIMN (-91.961).
LIMNSCNILIMN / SCNI
CapitalizationN/A3.99M-
EBITDAN/A8.11M-
Gain YTD-91.961-69.208133%
P/E RatioN/A0.29-
RevenueN/A1.15M-
Total CashN/A989K-
Total DebtN/A2.36M-
FUNDAMENTALS RATINGS
SCNI: Fundamental Ratings
SCNI
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
20
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
7
PRICE GROWTH RATING
1..100
94
P/E GROWTH RATING
1..100
99
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
LIMNSCNI
RSI
ODDS (%)
Bullish Trend 7 days ago
37%
Bullish Trend 7 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 7 days ago
38%
Bullish Trend 7 days ago
75%
Momentum
ODDS (%)
Bearish Trend 7 days ago
16%
Bullish Trend 7 days ago
78%
MACD
ODDS (%)
Bullish Trend 7 days ago
30%
Bullish Trend 7 days ago
71%
TrendWeek
ODDS (%)
Bearish Trend 7 days ago
26%
Bullish Trend 7 days ago
77%
TrendMonth
ODDS (%)
Bearish Trend 7 days ago
32%
Bearish Trend 7 days ago
89%
Advances
ODDS (%)
Bullish Trend 7 days ago
45%
Bullish Trend 7 days ago
75%
Declines
ODDS (%)
Bearish Trend 14 days ago
46%
Bearish Trend 14 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 7 days ago
36%
Bullish Trend 7 days ago
85%
Aroon
ODDS (%)
Bearish Trend 7 days ago
38%
Bearish Trend 7 days ago
88%
View a ticker or compare two or three
Interact to see
Advertisement
LIMN
Daily Signal:
Gain/Loss:
SCNI
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DXF2.640.28
+11.86%
Eason Technology Limited
RXO13.460.21
+1.58%
RXO
BSY42.410.56
+1.34%
Bentley Systems
PSFE7.950.01
+0.13%
Paysafe Limited
CPHC15.20N/A
-0.02%
Canterbury Park Holding Corp

LIMN and

Correlation & Price change

A.I.dvisor tells us that LIMN and SGMT have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that LIMN and SGMT's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LIMN
1D Price
Change %
LIMN100%
-6.56%
SGMT - LIMN
29%
Poorly correlated
-10.51%
AIM - LIMN
29%
Poorly correlated
-9.68%
LYEL - LIMN
24%
Poorly correlated
-6.70%
SCNI - LIMN
23%
Poorly correlated
+3.00%
ALT - LIMN
23%
Poorly correlated
-3.65%
More

SCNI and

Correlation & Price change

A.I.dvisor indicates that over the last year, SCNI has been closely correlated with TAOX. These tickers have moved in lockstep 73% of the time. This A.I.-generated data suggests there is a high statistical probability that if SCNI jumps, then TAOX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SCNI
1D Price
Change %
SCNI100%
+3.00%
TAOX - SCNI
73%
Closely correlated
+0.33%
SYRE - SCNI
43%
Loosely correlated
-0.91%
MBIO - SCNI
37%
Loosely correlated
-7.69%
BIVI - SCNI
34%
Loosely correlated
-1.20%
VANI - SCNI
32%
Poorly correlated
+1.13%
More